Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexicon Pharmaceuticals (LXRX) Receivables - Net (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Receivables - Net for 6 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net fell 31.36% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, down 31.36% year-over-year, with the annual reading at $2.4 million for FY2025, 31.36% down from the prior year.
  • Receivables - Net for Q4 2025 was $2.4 million at Lexicon Pharmaceuticals, up from $2.3 million in the prior quarter.
  • The five-year high for Receivables - Net was $47.4 million in Q1 2025, with the low at $261000.0 in Q1 2023.
  • Average Receivables - Net over 3 years is $5.6 million, with a median of $2.3 million recorded in 2025.
  • Peak annual rise in Receivables - Net hit 3009.24% in 2025, while the deepest fall reached 31.36% in 2025.
  • Over 3 years, Receivables - Net stood at $1.0 million in 2023, then skyrocketed by 243.86% to $3.5 million in 2024, then tumbled by 31.36% to $2.4 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $2.4 million, $2.3 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.